1. Adelaide Research & Scholarship

Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 21-27 of 27 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2012N-terminal pro-brain natriuretic peptide levels predict incident pulmonary arterial hypertension in SScThakkar, V.; Stevens, W.; Prior, D.; Byron, J.; Patterson, K.; Hissaria, P.; Moore, O.; Roddy, J.; Zochling, J.; Sahhar, J.; Nash, P.; Tymms, K.; Youssef, P.; Proudman, S.; Nikpour, M.; 2nd Systemic Sclerosis World Congress (2 Feb 2012 - 4 Feb 2012 : Madrid, Spain)
2013Anti-phospholipid antibodies in systemic sclerosis: prevalence and clinical correlationsMorrisroe, K.B.; Stevens, W.M.; Byron, J.; Thakkar, V.; Moore, O.; Proudman, S.; Nikpour, M.; Australian Scleroderma Interest Group,; 2012 Annual European Congress of Rheumatology (EULAR) (6 Jun 2012 - 9 Jun 2012 : Berlin, Germany)
2013N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosisThakkar, V.; Stevens, W.; Prior, D.; Moore, O.; Byron, J.; Patterson, K.; Hissaria, P.; Roddy, J.; Zochling, J.; Sahhar, J.; Nash, P.; Tymms, K.; Celermajer, D.; Gabbay, E.; Youssef, P.; Proudman, S.; Nikpour, M.; Australian Scleroderma Interest Group,; 2012 Annual European Congress of Rheumatology (EULAR) (6 Jun 2012 - 9 Jun 2012 : Berlin, Germany)
2013Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung diseaseMoore, O.; Goh, N.; Corte, T.; Rouse, H.; Hennessy, O.; Thakkar, V.; Byron, J.; Sahhar, J.; Roddy, J.; Gabbay, E.; Youssef, P.; Nash, P.; Zochling, J.; Proudman, S.; Stevens, W.; Nikpour, M.
2018Increased serum levels of adhesion molecules ICAM-1 and VCAM-1 in systemic sclerosis are not specific for pulmonary manifestationsThakkar, V.; Patterson, K.; Stevens, W.; Wilson, M.; Roddy, J.; Sahhar, J.; Proudman, S.; Hissaria, P.; Nikpour, M.
2016Multicentre randomised placebo-controlled trial of oral anticoagulation with apixaban in systemic sclerosis-related pulmonary arterial hypertension: the SPHInX study protocolCalderone, A.; Stevens, W.; Prior, D.; Nandurkar, H.; Gabbay, E.; Proudman, S.; Williams, T.; Celermajer, D.; Sahhar, J.; Wong, P.; Thakkar, V.; Dwyer, N.; Wrobel, J.; Chin, W.; Liew, D.; Staples, M.; Buchbinder, R.; Nikpour, M.
2017Validity of the PROMIS-29 in a large Australian cohort of patients with systemic sclerosisMorrisroe, K.; Stevens, W.; Huq, M.; Sahhar, J.; Ngian, G.S.; Zochling, J.; Roddy, J.; Proudman, S.; Nikpour, M.; Hill, C.; Lester, S.; Nash, P.; Rischmueller, M.; Strickland, G.; Thakkar, V.; Walker, J.

Discover